Document is current
Any future updates will be listed below
-
Authors
Chen, Jennifer H
Wanis, Kerollos Nashat
Rahman, Mahdia
Gianchandani, Ayushi
Bedrosian, Isabelle
Tamirisa, Nina
Yi, Min
Raghavendra, Akshara
Singh, Puneet
Teshome, Mediget
Sun, Susie
Kuerer, Henry
Hunt, Kelly K.
Meric-Bernstam, Funda
Adesoye, Taiwo https://orcid.org/0000-0001-8980-1266
- License Information
-
More Information
Article History
Received: 24 March 2026
Accepted: 3 April 2026
First Online: 22 April 2026
Disclosure
: KKH Medical Advisory Board ArmadaHealth, AstraZeneca, Daiichi Sankyo; Paid travel Merck Sharp and Dome; Research funding to MD Anderson Cairn Surgical, Lumicell; MT AstraZeneca (speaker honorarium) FM B reports personal fees from AstraZeneca Pharmaceuticals, Becton Dickinson, Biocartis NV, Calibr (a division of Scripps Research), Daiichi Sankyo, Dava Oncology, Debiopharm, EcoR1 Capital, eFFECTOR Therapeutics, Eleva tion Oncology, Exelixis, GT Aperion, Incyte, Jazz Pharmaceuticals, LigaChem Biosciences, Menarini Group, ModeX Therapeutics, Inc., Molecular Templates, Protai Bio, Ribometrix, SystImmune, TEMPUS, Vir Biotechnology, Zymeworks. Serves on an advisory role for Cybrexa Therapeutics, go Therapeutics, Guardant Health, Harbinger Health, Illumen Therapeutics, Kivu Biosciences, LOXO Oncology, Mersana Therapeutics, OnCusp Therapeutics, Sanofi Pharmaceuticals, Seagen (formerly Seattle Genetics), Theratechnologies Inc., Zentalis Pharmaceuticals. Sponsored research support has been provided to the institution from AstraZeneca, Daiichi Sankyo Co. Ltd., Debiopharm International, eFFECTOR Therapeutics, Guardant Health Inc., Jazz Pharmaceuticals, Zymeworks. Honoraria from Dav a Oncology. Travel related support has been provided by Cholangiocarcinoma Foundation, Dava Oncology, European Organisation for Research and Treatment of Cancer (EORTC), European Society for Medical Oncology (ESMO), Physician Education Resource (PER).
